With an immense pride and enthusiasm, Open Exploration Publishing Inc. is thrilled to announce the official acceptance and indexing of our journal, Exploration of Immunology, by Scopus, a globally esteemed abstract and citation database.This recognit...

Open ExplorationPublishing Inc.is proud to announce that its journals, Exploration of Medicine(EM)and Exploration of Targeted Anti-tumor Therapy(ETAT), have achieved their first Scopus CiteScore this month. This significant achievement follows their ...

With great honor, we announce that Prof. Stefan R. Bornstein has been officially appionted as the first Editor-in-Chief of Exploration of Endocrine and Metabolic Disease(EEMD) since November 2022.Professor Stefan Richard Bornstein is Chair and Direct...

With great honor, we announce that Prof.Eugenio Picanohas been officially appointed as the Editor-in-Chief ofExploration of Cardiology(EC), a three-year post that takes effect from January, 2023.Prof. Picanois theResearch Director at Italian National...

With great honor, we announce that Prof. Atanas G. Atanasovhas been officially appointed as the Editor-in-Chief ofExploration of Digital Health Technologies(EDHT), a three-year post that takes effect inOctorber 2022.Prof.Atanasovis Principle Investig...

With great honor, we announce that Prof. Maryam Tabrizian has been officially appointed as the Editor-in-Chief of Exploration of BioMat-X (EBMX), a three-year post that takes effect inSeptember 2022.Prof. Tabrizian is a Full Professor at Depart...

Open Exploration Publishing Inc. is proud to announce that its journalExploration of Targeted Anti-tumor Therapy (ETAT) has passed the scientific quality review and technical evaluation of PMC on 17 August, and will soon appear onPubMed Central (PMC)...

With great honor, we announce that Prof. Alejandro Cifuentes and Prof. Elena Ibañez have been officially appointed as the Editors-in-Chief of Exploration of Foods and Foodomics (EFF), a three-year post that takes effect in August 2022.Prof. Cifuentes...

With great honor, we announce that Prof. Fernando Albericio has been officially appionted as the first Editor-in-Chief of Exploration of Drug Science(EDS) since April 2022.Prof. Fernando Albericio holds a Ph.D. in Chemistry from the University of Bar...

With great honor, we announce that Prof. Giorgio Walter Canonica and Prof. Enrico Heffler have been officially appointed as the Editors-in-Chief of Exploration of Asthma & Allergy (EAA), a three-year post that takes effect in April 2022.Prof. Canonic...